Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.25B |
| 2 |
Home Depot
HD
|
+$645M |
| 3 |
Gilead Sciences
GILD
|
+$621M |
| 4 |
Navient
NAVI
|
+$609M |
| 5 |
Exelon
EXC
|
+$583M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Retail ETF
XRT
|
+$1.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$611M |
| 3 |
SLM Corp
SLM
|
+$564M |
| 4 |
CIE
Cobalt International Energy, Inc
CIE
|
+$403M |
| 5 |
DuPont de Nemours
DD
|
+$379M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 8.18% |
| 2 | Financials | 7.69% |
| 3 | Technology | 7.67% |
| 4 | Healthcare | 6.64% |
| 5 | Industrials | 5.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
CALL
Kroger
KR
$36.7B
| $8.65M | ﹤0.01% |
350,200
-243,000
| -41% | -$5.66M |
|
2477
Knowles
KN
$2.95B
| $8.65M | ﹤0.01% |
281,297
-37,459
| -12% | -$1.13M |
|
2478
PUT
Goodyear
GT
$2.09B
| $8.62M | ﹤0.01% |
310,400
+128,400
| +71% | +$3.35M |
|
2479
PUT
Core Laboratories
CLB
$455M
| $8.62M | ﹤0.01% |
+51,600
| New | +$9.18M |
|
2480
PUT
USA Compression Partners
USAC
$3.69B
| $8.61M | ﹤0.01% |
+335,100
| New | +$8.73M |
|
2481
CALL
Eastman Chemical
EMN
$7.69B
| $8.6M | ﹤0.01% |
98,500
-5,800
| -6% | -$504K |
|
|
SGY
2482
DELISTED
Stone Energy
SGY
| $8.59M | ﹤0.01% |
3,230
+59
| +2% | +$149K |
|
|
CRR
2483
DELISTED
Carbo Ceramics Inc.
CRR
| $8.58M | ﹤0.01% |
55,691
+18,002
| +48% | +$2.48M |
|
|
MVNR
2484
DELISTED
MAVENIR SYS INC COM STK (DE)
MVNR
| $8.58M | ﹤0.01% |
566,563
+3,193
| +0.6% | +$46.5K |
|
|
SNV
2485
DELISTED
Synovus
SNV
| $8.57M | ﹤0.01% |
351,379
+38,615
| +12% | +$900K |
|
2486
Crown Holdings
CCK
$13B
| $8.56M | ﹤0.01% |
172,099
-141,824
| -45% | -$6.8M |
|
2487
PUT
Stratasys
SSYS
$666M
| $8.54M | ﹤0.01% |
75,200
-19,100
| -20% | -$1.87M |
|
2488
Cooper Companies
COO
$14.2B
| $8.54M | ﹤0.01% |
251,956
-263,372
| -51% | -$8.7M |
|
2489
Ultragenyx Pharmaceutical
RARE
$2.46B
| $8.52M | ﹤0.01% |
189,863
+64,815
| +52% | +$2.67M |
|
|
CVSA
2490
Covista Inc
CVSA
$4.55B
| $8.52M | ﹤0.01% |
201,218
+83,047
| +70% | +$3.53M |
|
2491
Vanda Pharmaceuticals
VNDA
$304M
| $8.52M | ﹤0.01% |
526,471
+197,191
| +60% | +$2.63M |
|
|
HNT
2492
CALL
DELISTED
HEALTH NET INC
HNT
| $8.52M | ﹤0.01% |
205,000
+141,400
| +222% | +$5.27M |
|
2493
CVB Financial
CVBF
$4.02B
| $8.51M | ﹤0.01% |
531,053
+85
| +0% | +$1.28K |
|
2494
Invesco CurrencyShares Swiss Franc Trust
FXF
$411M
| $8.49M | ﹤0.01% |
77,022
+54,064
| +235% | +$5.95M |
|
2495
PUT
Synaptics
SYNA
$4.05B
| $8.48M | ﹤0.01% |
93,600
-2,400
| -3% | -$163K |
|
|
LO
2496
CALL
DELISTED
LORILLARD INC COM STK
LO
| $8.47M | ﹤0.01% |
139,000
-694,200
| -83% | -$40.4M |
|
2497
PUT
Logitech
LOGI
$14.8B
| $8.47M | ﹤0.01% |
+650,000
| New | +$8.8M |
|
2498
MasTec
MTZ
$22.7B
| $8.46M | ﹤0.01% |
274,305
+152,757
| +126% | +$5.76M |
|
2499
Artisan Partners
APAM
$2.86B
| $8.45M | ﹤0.01% |
149,040
+111,444
| +296% | +$6.38M |
|
|
SYT
2500
DELISTED
Syngenta Ag
SYT
| $8.44M | ﹤0.01% |
112,829
+5,994
| +6% | +$461K |
|
Similar funds
Goldman Sachs's Q2 2014 Portfolio in Review
As of Q2 2014, Goldman Sachs held 7,392 positions worth $319B, up 4.4% from $306B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Goldman Sachs's Q2 2014 filing shows 646 new, 2,991 increased, 3,008 reduced and 432 closed positions. Its largest new stake was Navient: 36,826,072 shares worth $652M. The largest sale was State Street SPDR S&P Retail ETF, an estimated $1.17B.
By sector, the portfolio is most concentrated in Energy at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Technology.
- Goldman Sachs's largest Q2 2014 buy was Navient: 36,826,072 shares worth $652M.
- Goldman Sachs added most to iShares Russell 2000 ETF in Q2 2014, an estimated $1.25B increase.
- Goldman Sachs's biggest Q2 2014 reduction was State Street SPDR S&P Retail ETF, cutting an estimated $1.17B.
- Goldman Sachs fully exited CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM in Q2 2014, selling an estimated $59.8M.
- Goldman Sachs's ten largest holdings make up 13% of its $319B portfolio in Q2 2014.
- Goldman Sachs opened 646 new positions and closed 432 in Q2 2014.
- Goldman Sachs's portfolio value rose 4.4% quarter-over-quarter to $319B.
Based on Goldman Sachs's 13F filing for Q2 2014, filed 14 Aug 2014.